FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

JA Wright

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Genes & Molecular Sequences

Physiology

Disorders

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
TI Kuschak; BC Kuschak; C L Taylor; JA Wright; Francis Wiener; Sabine Mai
c-Myc initiates illegitimate replication of the ribonucleotide reductase R2 gene.
TI Kuschak; BC Kuschak; G M Smith; JA Wright; Sabine Mai
Isolation of extrachromosomal elements by histone immunoprecipitation.
TI Kuschak; C Taylor; E McMillan-Ward; Sara J Israels; DW Henderson; J Frederic Mushinski; JA Wright; Sabine Mai
The ribonucleotide reductase R2 gene is a non-transcribed target of c-Myc-induced genomic instability.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of JA Wright (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2002: TI Kuschak; BC Kuschak; C L Taylor; JA Wright; Francis Wiener; Sabine Mai
c-Myc initiates illegitimate replication of the ribonucleotide reductase R2 gene.
Oncogene 2002;21(6):909-20.
2001: TI Kuschak; BC Kuschak; G M Smith; JA Wright; Sabine Mai
Isolation of extrachromosomal elements by histone immunoprecipitation.
BioTechniques 2001;30(5):1064-8, 1070-2.
1999: TI Kuschak; C Taylor; E McMillan-Ward; Sara J Israels; DW Henderson; J Frederic Mushinski; JA Wright; Sabine Mai
The ribonucleotide reductase R2 gene is a non-transcribed target of c-Myc-induced genomic instability.
Gene 1999;238(2):351-65.
1999: D N Chadee; Michael Hendzel; C P Tylipski; C D Allis; David P Bazett-Jones; JA Wright; James Davie
Increased Ser-10 phosphorylation of histone H3 in mitogen-stimulated and oncogene-transformed mouse fibroblasts.
The Journal of biological chemistry 1999;274(35):24914-20.
1999: A K Chan; S Persad; David W Litchfield; JA Wright
Ribonucleotide reductase R2 protein is phosphorylated at serine-20 by P34cdc2 kinase.
Biochimica et biophysica acta 1999;1448(3):363-71.
1999: James Davie; SK Samuel; Virginia A Spencer; Laurel T Holth; Deborah N Chadee; Cheryl P Peltier; Jian-Min Sun; Hou Yu Chen; JA Wright
Organization of chromatin in cancer cells: role of signalling pathways.
Biochemistry and cell biology = Biochimie et biologie cellulaire 1999;77(4):265-75.
1998: H Fan; C Villegas; A Huang; JA Wright
The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation.
Cancer research 1998;58(8):1650-3.
1998: H Fan; C Villegas; A K Chan; JA Wright
Myc-epitope tagged proteins detected with the 9E10 antibody in immunofluorescence and immunoprecipitation assays but not in western blot analysis.
Biochemistry and cell biology = Biochimie et biologie cellulaire 1998;76(1):125-8.
1997: H Fan; A Huang; C Villegas; JA Wright
The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(24):13181-6.
1997: A Huang; H Fan; W R Taylor; JA Wright
Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.
Cancer research 1997;57(21):4876-81.
1997: D N Chadee; C D Allis; JA Wright; James Davie
Histone H1b phosphorylation is dependent upon ongoing transcription and replication in normal and ras-transformed mouse fibroblasts.
The Journal of biological chemistry 1997;272(13):8113-6.
1996: M I Anazodo; E Duta; A D Friesen; JA Wright
Relative levels of inhibition of p24 gene expression by different 20-mer antisense oligonucleotide sequences targeting nucleotides + 1129 to + 1268 of the HIV-1 gag genome: an analysis of mechanism.
Biochemical and biophysical research communications 1996;229(1):305-9.
1996: H Fan; C Villegas; JA Wright
Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(24):14036-40.
1996: F M Amara; G M Smith; TI Kuschak; T L Takeuchi; JA Wright
A cis-trans interaction at the 3'-untranslated region of ribonucleotide reductase mRNA is regulated by TGF-beta 1, TGF-beta 2, and TGF-beta 3.
Biochemical and biophysical research communications 1996;228(2):347-51.
1996: H Fan; C Villegas; A Huang; JA Wright
Suppression of malignancy by the 3' untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs.
Cancer research 1996;56(19):4366-9.
1996: F M Amara; J Sun; JA Wright
Defining a novel cis-element in the 3'-untranslated region of mammalian ribonucleotide reductase component R2 mRNA. cis-trans-interactions and message stability.
The Journal of biological chemistry 1996;271(33):20126-31.
1996: F M Amara; J Entwistle; TI Kuschak; E A Turley; JA Wright
Transforming growth factor-beta1 stimulates multiple protein interactions at a unique cis-element in the 3'-untranslated region of the hyaluronan receptor RHAMM mRNA.
The Journal of biological chemistry 1996;271(25):15279-84.
1996: S Mohapatra; Xi Yang; JA Wright; E A Turley; Arnold H Greenberg
Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression.
The Journal of experimental medicine 1996;183(4):1663-8.
1996: R A Hurta; A Huang; JA Wright
Basic fibroblast growth factor selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed cells.
Journal of cellular biochemistry 1996;60(4):572-83.
1996: H Fan; C Villegas; JA Wright
A link between ferritin gene expression and ribonucleotide reductase R2 protein, as demonstrated by retroviral vector mediated stable expression of R2 cDNA.
FEBS letters 1996;382(1-2):145-8.
1995: M I Anazodo; H Salomon; A D Friesen; M A Wainberg; JA Wright
Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5'-LTR region of the viral genome.
Gene 1995;166(2):227-32.
1995: W R Taylor; D N Chadee; C David Allis; JA Wright; James Davie
Fibroblasts transformed by combinations of ras, myc and mutant p53 exhibit increased phosphorylation of histone H1 that is independent of metastatic potential.
FEBS letters 1995;377(1):51-3.
1995: F M Amara; R A Hurta; A Huang; JA Wright
Altered regulation of message stability and tumor promoter-responsive cis-trans interactions of ribonucleotide reductase R1 and R2 messenger RNAs in hydroxyurea-resistant cells.
Cancer research 1995;55(20):4503-6.
1995: M I Anazodo; M A Wainberg; A D Friesen; JA Wright
Inhibition of human immunodeficiency virus type 1 (HIV) gag gene expression by an antisense oligodeoxynucleotide phosphorothioate.
Leukemia 1995;9 Suppl 1():S86-8.
1995: D N Chadee; W R Taylor; R A Hurta; C David Allis; JA Wright; James Davie
Increased phosphorylation of histone H1 in mouse fibroblasts transformed with oncogenes or constitutively active mitogen-activated protein kinase kinase.
The Journal of biological chemistry 1995;270(34):20098-105.
1995: F M Amara; F Y Chen; JA Wright
Defining a novel cis element in the 3'-untranslated region of mammalian ribonucleotide reductase component R2 mRNA: role in transforming growth factor-beta 1 induced mRNA stabilization.
Nucleic acids research 1995;23(9):1461-7.
1995: A Huang; H Jin; JA Wright
Drug resistance and gene amplification potential regulated by transforming growth factor beta 1 gene expression.
Cancer research 1995;55(8):1758-62.
1995: M I Anazodo; M A Wainberg; A D Friesen; JA Wright
Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.
Journal of virology 1995;69(3):1794-801.
1995: R A Hurta; JA Wright
Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1.
Journal of cellular biochemistry 1995;57(3):543-56.
1994: F Y Chen; F M Amara; JA Wright
Defining a novel ribonucleotide reductase r1 mRNA cis element that binds to an unique cytoplasmic trans-acting protein.
Nucleic acids research 1994;22(22):4796-7.
1994: M Spearman; W R Taylor; Arnold H Greenberg; JA Wright
Antisense oligodeoxyribonucleotide inhibition of TGF-beta 1 gene expression and alterations in the growth and malignant properties of mouse fibrosarcoma cells.
Gene 1994;149(1):25-9.
1994: R A Hurta; JA Wright
Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H-ras transformed cell lines.
Journal of cellular physiology 1994;161(2):383-91.
1994: F Y Chen; F M Amara; JA Wright
Regulation of mammalian ribonucleotide reductase R1 mRNA stability is mediated by a ribonucleotide reductase R1 mRNA 3'-untranslated region cis-trans interaction through a protein kinase C-controlled pathway.
The Biochemical journal 1994;302 ( Pt 1)():125-32.
1994: A Huang; H Jin; JA Wright
Aberrant expression of basic fibroblast growth factor in NIH-3T3 cells alters drug resistance and gene amplification potential.
Experimental cell research 1994;213(2):335-9.
1994: F Y Chen; F M Amara; JA Wright
Posttranscriptional regulation of ribonucleotide reductase R1 gene expression is linked to a protein kinase C pathway in mammalian cells.
Biochemistry and cell biology = Biochimie et biologie cellulaire 1994;72(7-8):251-6.
1994: W R Taylor; JA Wright
A role for myn in Ha-ras transformation of mouse 10T1/2 fibroblasts.
Molecular carcinogenesis 1994;10(1):8-14.
1994: F M Amara; F Y Chen; JA Wright
Phorbol ester modulation of a novel cytoplasmic protein binding activity at the 3'-untranslated region of mammalian ribonucleotide reductase R2 mRNA and role in message stability.
The Journal of biological chemistry 1994;269(9):6709-15.
1994: A Huang; JA Wright
Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification.
Oncogene 1994;9(2):491-9.
1994: P Bhatia; W R Taylor; Arnold H Greenberg; JA Wright
Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28S-ribosomal RNA gene expression as RNA loading controls for northern blot analysis of cell lines of varying malignant potential.
Analytical biochemistry 1994;216(1):223-6.
1994: R A Hurta; JA Wright
Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H-ras transformed cell lines.
Journal of cellular physiology 1994;158(1):187-97.
1993: A K Chan; David W Litchfield; JA Wright
Phosphorylation of ribonucleotide reductase R2 protein: in vivo and in vitro evidence of a role for p34cdc2 and CDK2 protein kinases.
Biochemistry 1993;32(47):12835-40.
1993: SK Samuel; R A Hurta; M A Spearman; JA Wright; E A Turley; Arnold H Greenberg
TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan.
The Journal of cell biology 1993;123(3):749-58.
1993: F M Amara; F Y Chen; JA Wright
A novel transforming growth factor-beta 1 responsive cytoplasmic trans-acting factor binds selectively to the 3'-untranslated region of mammalian ribonucleotide reductase R2 mRNA: role in message stability.
Nucleic acids research 1993;21(20):4803-9.
1993: F Y Chen; F M Amara; JA Wright
Mammalian ribonucleotide reductase R1 mRNA stability under normal and phorbol ester stimulating conditions: involvement of a cis-trans interaction at the 3' untranslated region.
The EMBO journal 1993;12(10):3977-86.
1993: R S Belo; James C Jamieson; JA Wright
Studies on the effect of mevinolin (lovastatin) and mevastatin (compactin) on the fusion of L6 myoblasts.
Molecular and cellular biochemistry 1993;126(2):159-67.
1993: R A Hurta; Arnold H Greenberg; JA Wright
Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
Journal of cellular physiology 1993;156(2):272-9.
1993: W R Taylor; Arnold H Greenberg; E A Turley; JA Wright
Cell motility, invasion, and malignancy induced by overexpression of K-FGF or bFGF.
Experimental cell research 1993;204(2):295-301.
1992: C S Chiu; A K Chan; JA Wright
Inhibition of mammalian ribonucleotide reductase by cis-diamminedichloroplatinum(II).
Biochemistry and cell biology = Biochimie et biologie cellulaire 1992;70(12):1332-8.
1992: R A Hurta; JA Wright
Regulation of mammalian ribonucleotide reductase by the tumor promoters and protein phosphatase inhibitors okadaic acid and calyculin A.
Biochemistry and cell biology = Biochimie et biologie cellulaire 1992;70(10-11):1081-7.
1992: R A Hurta; Arnold H Greenberg; JA Wright
Transforming growth factor-beta 1 mediated alterations in ribonucleotide reductase gene expression in BALB/c 3T3 fibroblasts.
Journal of cellular physiology 1992;152(3):529-35.
1992: W R Taylor; S E Egan; Michael Mowat; Arnold H Greenberg; JA Wright
Evidence for synergistic interactions between ras, myc and a mutant form of p53 in cellular transformation and tumor dissemination.
Oncogene 1992;7(7):1383-90.
1992: James C Jamieson; S Wayne; R S Belo; JA Wright; M A Spearman
The importance of N-linked glycoproteins and dolichyl phosphate synthesis for fusion of L6 myoblasts.
Biochemistry and cell biology = Biochimie et biologie cellulaire 1992;70(6):408-12.
1992: R A Hurta; JA Wright
Alterations in the activity and regulation of mammalian ribonucleotide reductase by chlorambucil, a DNA damaging agent.
The Journal of biological chemistry 1992;267(10):7066-71.
1992: SK Samuel; R A Hurta; P Kondaiah; Nasreen Khalil; E A Turley; JA Wright; Arnold H Greenberg
Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-beta 1 (Ser223, 225).
The EMBO journal 1992;11(4):1599-605.
1991: R A Hurta; SK Samuel; Arnold H Greenberg; JA Wright
Early induction of ribonucleotide reductase gene expression by transforming growth factor beta 1 in malignant H-ras transformed cell lines.
The Journal of biological chemistry 1991;266(35):24097-100.
1991: M A Spearman; B C Ballon; J M Gerrard; Arnold H Greenberg; JA Wright
The inhibition of platelet aggregation of metastatic H-ras-transformed 10T1/2 fibroblasts with castanospermine, an N-linked glycoprotein processing inhibitor.
Cancer letters 1991;60(3):185-91.
1991: J E Damen; Arnold H Greenberg; JA Wright
Transformation and amplification of the K-fgf proto-oncogene in NIH-3T3 cells, and induction of metastatic potential.
Biochimica et biophysica acta 1991;1097(2):103-10.
1991: R A Hurta; JA Wright
Correlation between levels of ferritin and the iron-containing component of ribonucleotide reductase in hydroxyurea-sensitive, -resistant, and -revertant cell lines.
Biochemistry and cell biology = Biochimie et biologie cellulaire 1991;69(9):635-42.
1991: S E Egan; JA Wright; Arnold H Greenberg
Molecular determinants of metastatic transformation.
Environmental health perspectives 1991;93():91-5.
1991: M A Spearman; J E Damen; T Kolodka; Arnold H Greenberg; James C Jamieson; JA Wright
Differential effects of glycoprotein processing inhibition on experimental metastasis formation by T24-H-ras transformed fibroblasts.
Cancer letters 1991;57(1):7-13.
1991: J E Damen; M A Spearman; Arnold H Greenberg; JA Wright
Characterization of deoxyguanosine-resistant hypoxanthine-guanine phosphoribosyltransferase(-)metastatic variants altered in soybean-agglutinin-binding properties and cell-surface glycoproteins.
Journal of cancer research and clinical oncology 1991;117(4):305-12.
1990: JA Wright; A K Chan; B K Choy; R A Hurta; Grant McClarty; A Y Tagger
Regulation and drug resistance mechanisms of mammalian ribonucleotide reductase, and the significance to DNA synthesis.
Biochemistry and cell biology = Biochimie et biologie cellulaire 1990;68(12):1364-71.
1990: R A Hurta; JA Wright
Mammalian drug resistant mutants with multiple gene amplifications: genes encoding the M1 component of ribonucleotide reductase, the M2 component of ribonucleotide reductase, ornithine decarboxylase, p5-8, the H-subunit of ferritin and the L-subunit of ferritin.
Biochimica et biophysica acta 1990;1087(2):165-72.
1990: S E Egan; L Jarolim; S Rogelj; M Spearman; JA Wright; Arnold H Greenberg
Growth factor modulation of metastatic lung colonization.
Anticancer research 1990;10(5A):1341-6.
1990: JA Wright; S E Egan; Arnold H Greenberg
Genetic regulation of metastatic progression.
Anticancer research 1990;10(5A):1247-55.
1990: M C Gingras; L Jarolim; J Finch; George Bowden; JA Wright; Arnold H Greenberg
Transient alterations in the expression of protease and extracellular matrix genes during metastatic lung colonization by H-ras-transformed 10T1/2 fibroblasts.
Cancer research 1990;50(13):4061-6.
1990: L C Schwarz; T Inoue; T Irimura; J E Damen; Arnold H Greenberg; JA Wright
Relationships between heparanase activity and increasing metastatic potential of fibroblasts transfected with various oncogenes.
Cancer letters 1990;51(3):187-92.
1990: Grant McClarty; A K Chan; B K Choy; JA Wright
Increased ferritin gene expression is associated with increased ribonucleotide reductase gene expression and the establishment of hydroxyurea resistance in mammalian cells.
The Journal of biological chemistry 1990;265(13):7539-47.
1990: R A Hurta; JA Wright
Amplification of the genes for both components of ribonucleotide reductase in hydroxyurea resistant mammalian cells.
Biochemical and biophysical research communications 1990;167(1):258-64.
1990: S Wayne; James C Jamieson; M A Spearman; JA Wright
Studies on the effect of ketoconazole on the fusion of L6 myoblasts.
Molecular and cellular biochemistry 1990;92(2):137-46.
1990: L C Schwarz; JA Wright; M C Gingras; P Kondaiah; David Danielpour; M Pimentel; Michael B. Sporn; Arnold H Greenberg
Aberrant TGF-beta production and regulation in metastatic malignancy.
Growth factors (Chur, Switzerland) 1990;3(2):115-27.
1989: B K Choy; Grant McClarty; JA Wright
Transient elevation of ribonucleotide reductase activity, M2 mRNA and M2 protein in BALB/c 3T3 fibroblasts in the presence of 12-O-tetradecanoylphorbol-13-acetate.
Biochemical and biophysical research communications 1989;162(3):1417-24.
1989: J E Damen; A Y Tagger; Arnold H Greenberg; JA Wright
Generation of metastatic variants in populations of mutator and amplificator mutants.
Journal of the National Cancer Institute 1989;81(8):628-31.
1989: S E Egan; J J Broere; L Jarolim; JA Wright; Arnold H Greenberg
Co-regulation of metastatic and transforming activity of normal and mutant ras genes.
International journal of cancer. Journal international du cancer 1989;43(3):443-8.
1989: A Y Tagger; J E Damen; Arnold H Greenberg; JA Wright
Lack of correlation between deoxyribonucleotide pool sizes, spontaneous mutation rates and malignant potential in Chinese hamster ovary cells.
Journal of cancer research and clinical oncology 1989;115(5):429-34.
1989: Arnold H Greenberg; S E Egan; JA Wright
Oncogenes and metastatic progression.
Invasion & metastasis 1989;9(6):360-78.
1989: M A Spearman; S Wayne; James C Jamieson; JA Wright; E Gospodarek
Studies on glycosyltransferases in fusion-defective conA-resistant L6 rat myoblast cell lines.
The International journal of biochemistry 1989;21(5):531-4.
1988: L C Schwarz; M C Gingras; G Goldberg; Arnold H Greenberg; JA Wright
Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts.
Cancer research 1988;48(24 Pt 1):6999-7003.
1988: A Y Tagger; JA Wright
Molecular and cellular characterization of drug resistant hamster cell lines with alterations in ribonucleotide reductase.
International journal of cancer. Journal international du cancer 1988;42(5):760-6.
1988: L C Schwarz; J E Damen; Arnold H Greenberg; JA Wright
Altered responsiveness of metastatic versus non-metastatic fibroblasts to heparin-binding growth factors.
Cancer letters 1988;42(3):193-7.
1988: Grant McClarty; A K Chan; B K Choy; L Thelander; JA Wright
Molecular mechanisms responsible for the drug-induced posttranscriptional modulation of ribonucleotide reductase levels in a hydroxyurea-resistant mouse L cell line.
Biochemistry 1988;27(19):7524-31.
1988: Grant McClarty; Patricia N Tonin; P R Srinivasan; JA Wright
Relationships between reversion of hydroxyurea resistance in hamster cells and the co-amplification of ribonucleotide reductase M2 component, ornithine decarboxylase and P5-8 genes.
Biochemical and biophysical research communications 1988;154(3):975-81.
1988: B K Choy; Grant McClarty; A K Chan; L Thelander; JA Wright
Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.
Cancer research 1988;48(8):2029-35.
1988: Asher Begleiter; Marsha K Leith; Grant McClarty; S Beenken; Gerald J Goldenberg; JA Wright
Characterization of L5178Y murine lymphoblasts resistant to quinone antitumor agents.
Cancer research 1988;48(7):1727-35.
1987: Grant McClarty; A K Chan; Y Engstrom; JA Wright; L Thelander
Elevated expression of M1 and M2 components and drug-induced posttranscriptional modulation of ribonucleotide reductase in a hydroxyurea-resistant mouse cell line.
Biochemistry 1987;26(24):8004-11.
1987: A Y Tagger; J Boux; JA Wright
Hydroxy[14C]urea uptake by normal and transformed human cells: evidence for a mechanism of passive diffusion.
Biochemistry and cell biology = Biochimie et biologie cellulaire 1987;65(11):925-9.
1987: Arnold H Greenberg; S E Egan; L Jarolim; JA Wright
NK sensitivity of H-ras transfected fibroblasts is transformation- independent.
Cellular immunology 1987;109(2):444-50.
1987: S E Egan; JA Wright; L Jarolim; K Yanagihara; R H Bassin; Arnold H Greenberg
Transformation by oncogenes encoding protein kinases induces the metastatic phenotype.
Science (New York, N.Y.) 1987;238(4824):202-5.
1987: Arnold H Greenberg; S E Egan; L Jarolim; M C Gingras; JA Wright
Natural killer cell regulation of implantation and early lung growth of H-ras-transformed 10T1/2 fibroblasts in mice.
Cancer research 1987;47(18):4801-5.
1987: Grant McClarty; A K Chan; B K Choy; JA Wright
Reversion of hydroxyurea resistance, decline in ribonucleotide reductase activity, and loss of M2 gene amplification.
Biochemical and biophysical research communications 1987;145(3):1276-82.
1987: JA Wright; T G Alam; Grant McClarty; A Y Tagger; L Thelander
Altered expression of ribonucleotide reductase and role of M2 gene amplification in hydroxyurea-resistant hamster, mouse, rat, and human cell lines.
Somatic cell and molecular genetics 1987;13(2):155-65.
1987: S E Egan; G A McClarty; L Jarolim; JA Wright; I Spiro; G Hager; Arnold H Greenberg
Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells.
Molecular and cellular biology 1987;7(2):830-7.
1987: Patricia N Tonin; R L Stallings; M D Carman; J R Bertino; JA Wright; P R Srinivasan; W H Lewis
Chromosomal assignment of amplified genes in hydroxyurea-resistant hamster cells.
Cytogenetics and cell genetics 1987;45(2):102-8.
1987: M A Spearman; James C Jamieson; JA Wright
Studies on the effect of glycoprotein processing inhibitors on fusion of L6 myoblast cell lines.
Experimental cell research 1987;168(1):116-26.
1986: Grant McClarty; A K Chan; JA Wright
Hydroxyurea-induced conversion of mammalian ribonucleotide reductase to a form hypersensitive to bleomycin.
Cancer research 1986;46(9):4516-21.
1986: Grant McClarty; A K Chan; JA Wright
Characterization of a mouse cell line selected for hydroxyurea resistance by a stepwise procedure: drug-dependent overproduction of ribonucleotide reductase activity.
Somatic cell and molecular genetics 1986;12(2):121-31.
1985: Grant McClarty; A K Chan; D C Creasey; JA Wright
Ribonucleotide reductase: an intracellular target for the male antifertility agent, gossypol.
Biochemical and biophysical research communications 1985;133(1):300-5.